Download PDF
1 / Pages

Other users also viewed these articles

Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action Salvador Benlloch; Francesc Moncho; Jose Luis Górriz;
Nefrologia (English Version). 2024;44:129-38
Interaction between the stage of chronic kidney disease and diabetes mellitus as factors associated with mortality in chronic kidney disease patients: An external cohort study Laura E. Villegas Sierra; Melisa Buriticá Agudelo; Carlos Enrique Yepes Delgado; Yanett Marcela Montoya Jaramillo; Fabián Jaimes Barragan;
Nefrologia (English Version). 2022;42:540-8
Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao; José Luis Górriz Teruel; Luis D¿Marco; Enrique Garrigós; Gema Fernández-Fresnedo; Eugenia Espinel Garuz; Secundino Cigarrán Guldris; Jesús Arteaga Coloma; Nicolas Roberto Robles Pérez-Monteoliva; José Rafael Esteban de la Rosa; Luis Javier Nieto Iglesias; Alberto Ortiz Arduán; Juan Francisco Navarro-González;
10.1016/j.nefroe.2024.10.002